Zhao, Li
Zhou, Xuelei
Zhang, Ting
Mao, Wei
Chen, Linlin
Guo, Yiping
Liu, Xianchun
Zhang, Longyi
Li, Linji
Funding for this research was provided by:
the Nanchong Science and Technology Bureau (22SXQT0293, 22SXQT0293, 22SXQT0293, 22SXQT0293, 22SXQT0293, 22SXQT0293, 22SXQT0293, 22SXQT0293, 22SXQT0293)
Article History
Received: 22 December 2024
Accepted: 19 March 2025
First Online: 7 April 2025
Declarations
:
: The authors declare no competing interests.
: This was an effective dose-finding study based on Dixon’s up-and-down method. The study was approved by the Ethics Committee of Nanchong Central Hospital (2024, trial (003) No.) and registered in the China Clinical Trial Registry (Registration time: 15/01/2025; Available at ; Registration Number: ChiCTR2500095959 ). We confirm that our research is consistent with the Declaration of Helsinki.